Literature DB >> 9378967

CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis.

X G Tai1, K Toyooka, Y Yashiro, R Abe, C S Park, T Hamaoka, M Kobayashi, S Neben, H Fujiwara.   

Abstract

The induction of full activation or death in TCR-triggered T cells depends largely on whether appropriate costimulatory signals are provided. In this study, we show that the costimulation of CD9 on naive T cells during TCR stimulation results in transient, albeit potent, activation followed by apoptosis, rather than full activation. Anti-CD9 mAb synergized with suboptimal doses of anti-CD3 mAb in inducing T cell activation. [3H]TdR incorporation determined 2 days after CD9 costimulation was as potent as that induced by CD28 costimulation. In contrast to progressive T cell proliferation induced by CD28 costimulation, CD9 costimulation led to the induction of apoptosis of once-activated T cells. Although IL-2R expression was induced significantly earlier and to a greater degree after CD9 costimulation than after CD28 costimulation, CD9 costimulation only transiently produced a small amount of IL-2 and induced apparently low levels of bcl-xL compared with those observed in CD28 costimulation. Addition of rIL-2 to cultures of CD9 costimulation induced strikingly enhanced expression of bcl proteins, especially of bcl-xL, and protected TCR-stimulated T cells from apoptosis. These data indicate that CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis as the result of failure to generate a positive signal for sufficient levels of IL-2 production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378967

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Antibody cross-linking of human CD9 and the high-affinity immunoglobulin E receptor stimulates secretion from transfected rat basophilic leukaemia cells.

Authors:  A Higginbottom; I Wilkinson; B McCullough; F Lanza; D O Azorsa; L J Partridge; P N Monk
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

2.  Distinct MHC class II molecules are associated on the dendritic cell surface in cholesterol-dependent membrane microdomains.

Authors:  Sanjay Khandelwal; Paul A Roche
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

3.  Characterization of receptors for murine pregnancy specific glycoproteins 17 and 23.

Authors:  G N Sulkowski; J Warren; C T Ha; G S Dveksler
Journal:  Placenta       Date:  2011-06-12       Impact factor: 3.481

4.  The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation.

Authors:  H Kobayashi; O Hosono; S Iwata; H Kawasaki; M Kuwana; H Tanaka; N H Dang; C Morimoto
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

5.  The absence of Tssc6, a member of the tetraspanin superfamily, does not affect lymphoid development but enhances in vitro T-cell proliferative responses.

Authors:  Jacqueline M Tarrant; Joanna Groom; Donald Metcalf; Ruili Li; Bette Borobokas; Mark D Wright; David Tarlinton; Lorraine Robb
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

6.  HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells.

Authors:  Metka Lenassi; Gerard Cagney; Maofu Liao; Tomaz Vaupotic; Koen Bartholomeeusen; Yifan Cheng; Nevan J Krogan; Ana Plemenitas; B Matija Peterlin
Journal:  Traffic       Date:  2010-01       Impact factor: 6.215

7.  Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance.

Authors:  I Tachibana; M E Hemler
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

8.  Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.

Authors:  Dhruv Kumar; Dwijendra Gupta; Sharmila Shankar; Rakesh K Srivastava
Journal:  Oncotarget       Date:  2015-02-20

9.  Tetraspanin CD9 Limits Mucosal Healing in Experimental Colitis.

Authors:  María Laura Saiz; Danay Cibrian; Marta Ramírez-Huesca; Daniel Torralba; Olga Moreno-Gonzalo; Francisco Sánchez-Madrid
Journal:  Front Immunol       Date:  2017-12-19       Impact factor: 7.561

Review 10.  Function and Dynamics of Tetraspanins during Antigen Recognition and Immunological Synapse Formation.

Authors:  Vera Rocha-Perugini; Francisco Sánchez-Madrid; Gloria Martínez Del Hoyo
Journal:  Front Immunol       Date:  2016-01-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.